SEC Form 4/A · accession 0001140361-16-069204
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Daniel K Spiegelman
Officer — EVP, Chief Financial Officer
Period of report
May 31, 2016
Accepted (ET)
Jun 8, 2016 · 8:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) Common StockF1,F2 | $39.06 | May 31, 2016 | M | 16,896 | D | Nov 29, 2012 | May 28, 2022 | Common Stock | 16,896 | 2,604 | D |
Explanation of responses
- F1This amendment is being filed solely to correct the fact that the original filing inadvertently stated that the securities were acquired when in fact they were disposed of in this transaction.
- F2Reflects the number of stock options outstanding after the transaction from this specific stock option grant.